Kimberly-Clark (KMB) is close to selling its Kleenex and tissue businesses outside North America for approximately $3.5B, Lauren Thomas and Ben Dummett of The Wall Street Journal reports. This move is part of an attempt by the company to focus on more profitable areas, people familiar with the matter told the Journal. The company is set to sell the division to Suzano (SUZ) and a deal could be completed as soon as Thursday, the sources added.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KMB:
- M&A News: Kimberly-Clark Eyes $3.5B Global Tissue Sale amid Portfolio Overhaul
- Joint Corp. appoints Karrmann as Director
- Kimberly-Clark Transfers Stock Listing to Nasdaq
- Kimberly-Clark to transfer its U.S. stock exchange listing to Nasdaq
- Kimberly Clark’s Strategic Reorganization and Growth Potential Earns Buy Rating